Autophagy
13
2
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
1 terminated out of 13 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (13)
Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy
Mitophagy and Mitochondrial DNA Dynamics During Ramadan Dry Fasting vs 16:8 Time-Restricted Feeding
Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.
Fasting Mimicking Diet and Autophagy
Autophagy Markers in Endometrial Polyps
Hypoxia-induced Autophagy in the Pathogenesis of MAP
Regulatory Network and Diagnostic Value of Key Autophagy-related Genes in Sepsis
Time Course for Fasting-induced Autophagy in Humans
ATG5 as a Serum Marker of Autophagy in Psoriatic Patient
The Basel Enteral High Protein Study
A Study of Exosome Proteomics and Hemodynamics in Sepsis
Correlation Between Autophagy-related Proteins and Inflammatory Markers in Hemodialysis Patients
Expression of LC3-I, LC3-II & Beclin 1 in Vitiligo